InsidersTradesSigma
우진비앤지 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 우진비앤지 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 우진비앤지 has recorded 39 reports. Market capitalisation: €16.1bn. The latest transaction was reported on 6 July 2026 (Other). Among the most active insiders: 강재구. Every trade is free.
39
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
4 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,318 of 25,567 companies
37.2
score / 100
Value49
Quality25
FCF yld6.5%
Earn yld-11%
EV/EBITDA9.5x
ROE·
Gross mgn30%
Net mgn-3.2%
Debt/EBITDA6.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations39 total
25 of 39 declarations
About 우진비앤지
우진비앤지 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.